Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Laxmee Ramkhelawon"'
Autor:
Erick Auma, Tom Hall, Simran Chopra, Sam Bilton, Laxmee Ramkhelawon, Fahimah Amini, Anna Calvert, Gayatri Amirthalingam, Christine E. Jones, Nick Andrews, Paul T. Heath, Kirsty Le Doare
Publikováno v:
Vaccines, Vol 11, Iss 2, p 357 (2023)
Vaccination during pregnancy could protect women and their infants from invasive Group B Streptococcus (GBS) disease. To understand if neonatal dried blood spots (DBS) can be used to determine the amount of maternally derived antibody that protects i
Externí odkaz:
https://doaj.org/article/61a36d2e35e24b1486f82ba4b475d8aa
Autor:
Fahimah Amini, Erick Auma, Yingfen Hsia, Sam Bilton, Tom Hall, Laxmee Ramkhelawon, Paul T Heath, Kirsty Le Doare
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0248218 (2021)
BackgroundIncreasingly, vaccine efficacy studies are being recommended in low-and-middle-income countries (LMIC), yet often facilities are unavailable to take and store infant blood samples correctly. Dried blood spots (DBS), are useful for collectin
Externí odkaz:
https://doaj.org/article/91ac2214bf2740deafce0938d82a8901
Autor:
Clara Carreras-Abad, Madeleine Cochet, Tom Hall, Laxmee Ramkhelawon, Asma Khalil, Elisabeth Peregrine, Latha Vinayakarao, Sharmila Sivarajan, Rosol Hamid, Tim Planche, Elizabeth Sheridan, Stephen Winchester, Jane Plumb, Abdelmajid Djennad, Nick Andrews, Kirsty Le Doare, Paul Heath
Publikováno v:
Health Technology Assessment, Vol 23, Iss 67 (2019)
Background: Group B streptococcus is the leading cause of infection in infants. Currently, intrapartum antibiotic prophylaxis is the major strategy to prevent invasive group B streptococcus disease. However, intrapartum antibiotic prophylaxis does no
Externí odkaz:
https://doaj.org/article/915b6b54c06c40d59c3c14642b5bd4f0
Autor:
Anna Calvert, Gayatri Amirthalingam, Nick Andrews, Sneha Basude, Matthew Coleman, Hannah Cuthbertson, Anna England, Vanessa Greening, Bassam Hallis, Edward Johnstone, Christine E Jones, Konstantinos Karampatsas, Asma Khalil, Kirsty Le Doare, Mary Matheson, Elisabeth Peregrine, Matthew D Snape, Manu Vatish, Paul T Heath, Agnieszka Burtt, Wendy Byrne, Angelika Capp, Lotoyah Carty, Krina Chawla, Sarah Collins, Emily Cornish, Olwenn Daniel, Jessica Fretwell, Andrew Gorringe, Teresa Gubbins, Tom Hall, Susan Johnston, Uzma Khan, Suzy Lim, Nicki Martin, Ella Morey, Jude Mossop, Katie O'Brien, Nelly Owino, Deborah Powell, Laxmee Ramkhelawon, Helen Ratcliffe, Hannah Roberts, Fenella Roseman, Laura Sparks, Lorraine Stapley, Stephen Taylor, Fiona Walbridge, Rosie Watts, Susan J. Wellstead, Tabitha Wishlade
Publikováno v:
The Lancet Microbe. 4:e300-e308
Background: pertussis vaccination in pregnancy is recommended in many countries to provide protection to young infants. The best timing for this vaccination is uncertain. In the UK, vaccination is recommended between 16 weeks and 32 weeks of gestatio
Publikováno v:
Infection and Drug Resistance. 13:1263-1272
Group B streptococcus (GBS) causes a high burden of neonatal and infant disease globally. Implementing a vaccine for pregnant women is a promising strategy to prevent neonatal and infant GBS disease and has been identified as a priority by the World
Autor:
Laxmee Ramkhelawon, Vicki Chalker, T. Planche, Irene M. Monahan, Abdelmajid Djennad, Kirsty Le Doare, Ka-Ning To, Clara Carreras-Abad, Paul T. Heath
Publikováno v:
The Journal of infection. 82(5)
Autor:
Jane Plumb, Stephen Winchester, Paul T. Heath, Rosol Hamid, Latha Vinayakarao, Madeleine Cochet, Sharmila Sivarajan, Tom Hall, T. Planche, Kirsty Le Doare, Elisabeth Peregrine, Clara Carreras-Abad, Asma Khalil, Elizabeth Sheridan, Nick Andrews, Abdelmajid Djennad, Laxmee Ramkhelawon
Publikováno v:
Health Technology Assessment, Vol 23, Iss 67 (2019)
Group B streptococcus is the leading cause of infection in infants. Currently, intrapartum antibiotic prophylaxis is the major strategy to prevent invasive group B streptococcus disease. However, intrapartum antibiotic prophylaxis does not prevent ma
Publikováno v:
Infection and Drug Resistance
Group B streptococcus (GBS) causes a high burden of neonatal and infant disease globally. Implementing a vaccine for pregnant women is a promising strategy to prevent neonatal and infant GBS disease and has been identified as a priority by the World